CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion

This article is the result of a round-table discussion organised by ESMO Open in Vienna in December 2017. Its purpose is to discuss the background and advances in the evidence regarding cyclin-dependent kinase 4/6 inhibitors (palbociclib, ribociclib and abemaciclib) in the treatment of metastatic an...

Descripción completa

Detalles Bibliográficos
Autores principales: Preusser, Matthias, De Mattos-Arruda, Leticia, Thill, Marc, Criscitiello, Carmen, Bartsch, Rupert, Ruhstaller, Thomas, de Azambuja, Evandro, Zielinski, Christoph C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109817/
https://www.ncbi.nlm.nih.gov/pubmed/30167331
http://dx.doi.org/10.1136/esmoopen-2018-000368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109817/
https://www.ncbi.nlm.nih.gov/pubmed/30167331
http://dx.doi.org/10.1136/esmoopen-2018-000368

Ejemplares similares